Mohamed Riadh T.
- Country
- France
- Department
- Nephrology
Research Overview
- THINK - intensification of blood pressure lowering Therapeutics based on diuretics versus usual management for uncontrolled Hypertension IN patients with moderate to severe chronic Kidney disease: an open label, cluster randomized controlled, phase 3 trial
- Evaluation of Immunosuppressive Therapy Discontinuation Versus Maintenance in ANCA-Associated Vasculitis with End-Stage Renal Disease: A Randomized Multicenter Trial
Data & Insights
Has run more than one trial at 19 of 77 partner sites.
Specializations
Renal Disease Management
This investigator specializes in the study of end-stage renal disease (ESRD) and its complex management protocols, particularly in relation to autoimmune conditions.
- End-stage renal disease treatment optimization
- Immunosuppressive therapy management
- Long-term patient outcomes
The research focuses on developing effective treatment strategies for patients with severe kidney dysfunction.
Autoimmune Disorders
The investigator conducts research in ANCA-associated vasculitis (AAV), examining innovative approaches to immunosuppressive treatment protocols.
- Vasculitis treatment strategies
- Autoimmune disease management
- Therapeutic intervention assessment
Their work explores the intersection of autoimmune conditions and renal complications.
Immunotherapy Research
The investigator evaluates immunosuppressive therapy optimization in complex cases involving both renal and autoimmune conditions.
- Immunosuppression protocols
- Treatment discontinuation effects
- Patient survival outcomes
Their research examines the balance between immunosuppression maintenance and discontinuation in specific patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.